Report Code: A00575 | Pages: 245 | Jun 2022 | 15213 Views | ||
Author(s) : Suraj S, Prathmesh B , Onkar S | Tables: 150 | Charts: 61 |
|
The global specialty enzymes market size was valued at $1.2 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031. Enzyme is a substance that acts as a catalyst in living organisms, regulating the rate at which chemical reactions proceed without itself being altered in the process. Biological processes that occur within all living organisms are chemical reactions, and most are regulated by enzymes. Without enzymes, many of these reactions would not take place at a perceptible rate. Enzymes catalyze all aspects of cell metabolism.
This includes digestion of food, in which large nutrient molecules (such as proteins, carbohydrates, and fats) are broken down into smaller molecules, conservation and transformation of chemical energy and construction of cellular macromolecules from smaller precursors. Many inherited human diseases, such as albinism and phenylketonuria, result from a deficiency of a particular enzyme. Enzymes also have valuable industrial and medical applications. Use of enzymes in medicine include killing disease-causing microorganisms, promoting wound healing, and diagnosing certain diseases.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the specialty enzymes market due to the implementation of lockdown in many countries. The COVID-19 pandemic creates difficulty for pharmaceutical industry to focus on R&D activities including biosimilar development. These measures had a significant impact on the global economy, affecting a variety of industries. In addition, there is delay in product approval and product launch due to pandemic situations which further restricts the expansion of biosimilar market. Furthermore, most of the clinical trials are postponed to avoid spread of infections which slows down the drug development process.
Pharmaceutically important enzymes are an important component of the pharmaceutical market. They are broadly defined as prodrugs that target a specific biological reversible or irreversible reaction to treat a particular disease. Enzymes used for pharmaceutical applications include cysteine proteinases, asparaginase, streptokinase, urokinase, deoxyribonuclease I, hyaluronidase, and glucocerebrosidase. Immobilized enzymes are also used in the pharmaceutical industry.
The specialty enzymes market size is expected to witness moderate growth during the forecast period, owing to increase in prevalence of chronic diseases such as cancer and rheumatoid arthritis. Furthermore, expansion of food industries drives the demand of specialty enzymes. The enzymes such as lipases, amylases, proteases, rennet, pectinases, invertases, cellulases, and glucose oxidase plays an important role in food processing industry. However, the complexities in biosimilars development may hinder the growth of market.
The specialty enzymes market share is segmented on the basis of application, source, type and region. Based on application market is classified into pharmaceuticals, biotechnology research & development and diagnostics. On the basis of source, the market is bifurcated into microorganisms, plants and animals. By type market is divided into carbohydrases, proteases, lipases, polymerases & nucleases and other enzymes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type Segment review
By type, the specialty enzymes market trends is divided into carbohydrases, proteases, lipases, polymerases & nucleases and other enzymes. Carbohydrases segment was the highest revenue contributor to the market. Owing to increase in consumption of dietary supplements and digestive enzymes.
The polymerase & nucleases segment is estimated to be the fastest growing segment during the specialty enzymes market forecast period. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS. Thus, upsurge in prevalence of cancer propels the growth of this segment.
Application Segment Review
By application, the pharmaceuticals segment was the highest revenue contributor to the market. This is owing to the rise in demand of specialty enzymes in drug synthesis and increase in R&D activities for development of novel probiotic drinks and supplements.
The diagnostics segment is estimated to be the fastest growing segment. Owing to increase in prevalence of various diseases such as cancer, diabetes, heart diseases and renal disorders drives the growth of market.
Source Segment Review
By source, the microorganism’s segment was the highest revenue contributor to the market. Due to increasing use of amylases in biotechnology and pharmaceutical industries would drive the microorganism-derived specialty enzymes market growth.
The animal’s segment is fastest growing segment during the forecast period. Owing to rise in prevalence of digestive disorders and rise in demand of animal-derived enzymes as health supplements drives the growth of market.
Region Segment Review
Region wise, the specialty enzymes market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the largest shareholder in the specialty enzymes market analysis in 2021. Rise in number of specialty enzymes product approvals and product launch for the treatment of diseases contributes in the growth market.
Asia Pacific is estimated to grow fastest during the forecast period. Owing to increase in incidences of cardiovascular diseases, high prevalence of various cancers and rise in product launches in the region.
Key players operating in the global specialty enzymes market oportunity include Alphazyme LLC, Amano Enzyme, Antozyme Biotech, Enzyme Development Corporation, BBI Solution, Biocatalyst, Novoenzymes, Specialty Enzymes and Probiotics, International Flavors and Fragrances Inc and Enzyme Supplies Ltd.
KEY BENEFITS FOR STAKEHOLDERS
Specialty Enzymes Market Report Highlights
Aspects | Details |
---|---|
By Application |
|
By Source |
|
By Type |
|
By Region |
|
Key Market Players | International Flavor & Fragrance Inc, Biocatalyst, BBI Solutions, Enzyme Development Corporation, Amano Enzyme, Alphazyme LLC, Enzyme Supplies Limited, Antozyme Biotech, Specialty Enzyme and Probiotics, Novozymes |
Loading Table Of Content...
This section provides opinions of top level CXOs in the specialty enzymes market. According to the CXOs, specialty enzymes have gained popularity in recent years, owing to their potential applications in various industries such as pharmaceutical, biotechnology research, and diagnostics.
By type, the specialty enzyme market includes the carbohydrase, proteases, lipases, polymerases & nucleases, and other enzymes. Specialty enzymes have application in treatment of various diseases such as cancer, arthritis, and liver diseases.
Factors such as increase in use of specialty enzymes in the diagnostic industry, rise in application of enzymes in the food industry, and rise in development of advanced specific enzymes drugs drive growth of the specialty enzymes market. In addition, increase in geriatric population and rise in prevalence of various diseases are expected to contribute toward growth of the specialty enzymes market.
North America is expected to witness highest growth, in terms of revenue, owing to rise in incidences of cancer patients, presence of key players for manufacturing and developing of specialty enzymes, and expanding food industry in the region.
However, huge maintenance cost of enzyme products and rise in safety concerns for contaminated specialty enzymes hamper the market growth.
A. Few upcomming trends include the increased utilization of specialty enzymes in probiotic drinks and other digestive supplements for improving gut health.
A. Leading application of specialty enzyme is pharmaceutical due the increased usage of specialty enzymes in drug manufacturing and in gene therapy
A. North America region dominated the specialty enzyme market in 2021. This was mainly due to the rise in product approvals and increase in awareness regarding the consumption of specialty enzymes (probiotic drinks and digestive enzyme related products)
A. The global specialty enzymes market was valued at $1,166.1 million in 2021 registering a CAGR of 6.7% from 2022 to 2031
A. Novozyme, International Flavors & Fragrances Inc. and Roche are few top companies operating in Specialty Enzymes Market
A. Product launch, acquisition and collaboration are the top 3 strategies executed by major players from 2018-2021
A. Asia Pacific is the most lucrative regional market for Specialty Enzymes Market in 2021 and is expected to continue this trend during the forecast period.
A. Amylases are the widely utilized type of Carbohydrase enzyme specially in digestive tonics for hydrolyzing the starch molecules into polymers composed of glucose units
Start reading instantly.
This Report and over 53,621+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers